Topic: Excessive pricing

Spanish court awards hotel €1.1 million in hybrid antitrust lawsuit

A Spanish court has awarded a hotel group €1.1 million in a hybrid follow-on and standalone damages lawsuit seeking compensation from a media royalty collection association for charging discriminatory and excessive fees.

08 February 2023

Virginia judge denies federal injunction against railroad

CSX Transportation cannot challenge railroads’ common carrier status and immunity from antitrust injunctions, a Virginia federal court has held.

31 January 2023

South Africa seeks toughest penalty in face mask cartel probe

South Africa’s antitrust watchdog has asked the country’s specialist competition tribunal to impose the harshest possible fines on two personal protective equipment suppliers that it says fixed prices and divided the market during the height of the covid-19 pandemic.

27 January 2023

Dutch enforcer probes drugmakers over excessive pricing and tying

The Dutch competition authority has launched a preliminary investigation to determine if three pharmaceutical companies are tying their services and charging excessive prices to both healthcare and insurance providers.

25 January 2023

California judge dismisses antitrust claims against Edison

Three former Southern California Edison employees failed to allege that their former employer illegally prevented them from doing electrical work in the state, a federal court has ruled.

13 January 2023

SAMR fines academic database for excessive pricing

China’s antitrust watchdog has fined an online academic literature database €12.1 million for abusing its dominance by imposing excessively high subscription fees and forcing users into exclusivity arrangements.

09 January 2023

Israel imposes first-ever excessive pricing fine

Israel’s Competition Authority has fined drug distributor MBI Pharma €2.2 million for abusing its dominance by charging unfairly high prices for a life-saving genetic disorder treatment drug, marking the enforcer’s first-ever excessive pricing infringement decision.

14 December 2022

Market definition in CMA’s hydrocortisone decision “makes no sense”, drugmaker claims

The market definition used by the UK’s Competition and Markets Authority when fining Auden McKenzie for excessive pricing wrongly excluded a competitor’s more expensive substitute product, counsel to the sanctioned drugmaker has claimed.

14 December 2022

Lithuania issues largest-ever cartel fines

Lithuania’s Competition Council has levied a record €72 million cartel fine on eight pharmaceutical companies and an industry association that conspired to influence the government when it set new maximum prices for certain drugs.

13 December 2022

Indian court orders enforcer to reissue tyre cartel decision

India’s specialist antitrust tribunal has ordered the country's competition watchdog to reduce the €208 million price-fixing fines it levied against five tyre companies, due to “inadvertent and arithmetical” calculation errors and to save the wider market.

06 December 2022

Unlock unlimited access to all Global Competition Review content